1-20 of 41
Authors: Arnault Tauziède-Espariat
Journal Article
Nanopore sequencing as a cutting-edge technology for medulloblastoma classification Get access
Neuro-Oncology, noae279, https://doi.org/10.1093/neuonc/noae279
Published: 28 December 2024
Journal Article
PATH-37. A NEW SUBTYPE OF DIFFUSE MIDLINE GLIOMA, H3 K27 AND BRAF/FGFR1 CO-ALTERED, EXHIBITS SPECIFIC BIOLOGICAL CHARACTERISTICS AND NEW THERAPEUTIC VULNERABILITIES
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii187, https://doi.org/10.1093/neuonc/noae165.0736
Published: 11 November 2024
Journal Article
BIOM-51. MOLECULAR SUBTYPES, CLINICAL CHARACTERISTICS, AND THERAPEUTIC IMPLICATIONS FOR CNS TUMORS WITHBCOR/BCORL1 FUSION/INTERNAL TANDEM DUPLICATION
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii31, https://doi.org/10.1093/neuonc/noae165.0123
Published: 11 November 2024
Journal Article
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors Get access
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2102–2112, https://doi.org/10.1093/neuonc/noae122
Published: 02 August 2024
Journal Article
HGG-16. PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMA OF METHYLATION-BASED RTK2A AND RTK2B SUBCLASSES PRESENT DISTINCT RADIOLOGICAL AND HISTOMOLECULAR FEATURES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.300
Published: 18 June 2024
Journal Article
ETMR-23. CNS SARCOMAS WITHCIC- ORATXN1-ALTERATIONS — A META-ANALYSIS OF CLINICAL AND MOLECULAR FEATURES IN A LARGE SERIES OF PATIENTS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.193
Published: 18 June 2024
Journal Article
ETMR-15. RECLASSIFICATION OF CHILDHOOD CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTODERMAL TUMOR: CLINICAL FEATURES AND OUTCOME
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.185
Published: 18 June 2024
Journal Article
MDB-24. SHH MEDULLOBLASTOMA WITH SMO MUTATION BEFORE THE AGE OF 5YEARS OLD
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.473
Published: 18 June 2024
Journal Article
DIPG-44. DIFFUSE MIDLINE GLIOMA, H3K27-ALTERED: A COMPREHENSIVE CLINICAL AND BIOMOLECULAR LANDSCAPE OF THE NON-PONTINE TUMORS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.097
Published: 18 June 2024
Journal Article
ETMR-19.BCOR/L1-ALTERATIONS REWIRE HISTONE REGULATION TO INDUCE ONCOGENIC PATHWAYS IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.189
Published: 18 June 2024
Journal Article
MDB-12. NANOPORE SEQUENCING AS A CUTTING-EDGE TECHNOLOGY FOR MEDULLOBLASTOMA CLASSIFICATION
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.461
Published: 18 June 2024
Journal Article
NFS-02. MEDULLOBLASTOMAS WITH ELP1 PATHOGENIC VARIANTS: A WEAKLY PENETRANT SYNDROME WITH A RESTRICTED SPECTRUM IN A LIMITED AGE WINDOW
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.560
Published: 18 June 2024
Journal Article
Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling
Neuro-Oncology, Volume 26, Issue 3, March 2024, Pages 553–568, https://doi.org/10.1093/neuonc/noad161
Published: 13 September 2023
Includes: Multimedia
Journal Article
DIPG-43. CLINICAL AND MOLECULAR CHARACTERISTIC OF A NEW SUBTYPE OF DMG, H3K27-ALTERED WITH MAPK-ACTIVATING CO-DRIVER MUTATIONS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i22–i23, https://doi.org/10.1093/neuonc/noad073.090
Published: 12 June 2023
Journal Article
HGG-17. SINGLE-CELL AND SPATIAL ANALYSES DECIPHER THE UNIQUE INVASIVE GROWTH PATTERN OF GLIOMATOSIS CEREBRI
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i42–i43, https://doi.org/10.1093/neuonc/noad073.166
Published: 12 June 2023
Journal Article
EPEN-02. OPTIMISING BIOMARKERS FOR ACCURATE EPENDYMOMA DIAGNOSIS, PROGNOSTICATION AND STRATIFICATION WITHIN INTERNATIONAL CLINICAL TRIALS: A BIOMECA STUDY
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i26–i27, https://doi.org/10.1093/neuonc/noad073.106
Published: 12 June 2023
Journal Article
DIPG-38. PATIENT-DERIVED THREE-DIMENSIONAL AVATARS REVEAL CELL-AUTONOMOUS MECHANISMS DRIVING INVASION AND METASTATIC PROGRESSION IN DIFFUSE MIDLINE GLIOMAS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i21–i22, https://doi.org/10.1093/neuonc/noad073.085
Published: 12 June 2023
Journal Article
LGG-17. EPIGENETICALLY DEFINED ANGIOCENTRIC GLIOMAS MAY LACK ANGIOCENTRIC GROWTH AND INSTEAD SHOW A VARIETY OF GROWTH PATTERNS
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i59–i60, https://doi.org/10.1093/neuonc/noad073.227
Published: 12 June 2023
Journal Article
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
Neuro-Oncology, Volume 25, Issue 10, October 2023, Pages 1871–1882, https://doi.org/10.1093/neuonc/noad055
Published: 14 March 2023
Journal Article
PATH-12. A new powerful tool to simultaneously deliver DNA methylation profile and driver fusions detection based on Nanopore Sequencing
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i161, https://doi.org/10.1093/neuonc/noac079.596
Published: 03 June 2022
